Torthaí cuardaigh - Bruce R. Blazar

Beachtaigh na torthaí
  1. 1
    Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation?

    Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? de réir Robert Zeiser, Bruce R. Blazar

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

    Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy de réir Robert Zeiser, Bruce R. Blazar

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD

    How ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD de réir Samantha Jaglowski, Bruce R. Blazar

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Acute graft-versus-host disease: from the bench to the bedside

    Acute graft-versus-host disease: from the bench to the bedside de réir Gèrard Socié, Bruce R. Blazar

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    T CELL DEPLETION FOR GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS

    T CELL DEPLETION FOR GRAFT-VERSUS-HOST-DISEASE PROPHYLAXIS de réir Daniel A. Vallera, Bruce R. Blazar

    Foilsithe / Cruthaithe 1989
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease

    ROCK2, a critical regulator of immune modulation and fibrosis has emerged as a therapeutic target in chronic graft-versus-host disease de réir Alexandra Zanin‐Zhorov, Bruce R. Blazar

    Foilsithe / Cruthaithe 2021
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Pathogenesis of acute graft‐versus‐host disease: from intestinal microbiota alterations to donor T cell activation

    Pathogenesis of acute graft‐versus‐host disease: from intestinal microbiota alterations to donor T cell activation de réir Robert Zeiser, Gèrard Socié, Bruce R. Blazar

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    B-cell targeting in chronic graft-versus-host disease

    B-cell targeting in chronic graft-versus-host disease de réir Robert Zeiser, Stefanie Sarantopoulos, Bruce R. Blazar

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Thymic T-cell development in allogeneic stem cell transplantation

    Thymic T-cell development in allogeneic stem cell transplantation de réir Werner Krenger, Bruce R. Blazar, Georg A. Holländer

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Advances in graft-versus-host disease biology and therapy

    Advances in graft-versus-host disease biology and therapy de réir Bruce R. Blazar, William J. Murphy, Mehrdad Abedi

    Foilsithe / Cruthaithe 2012
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Recent advances in graft‐versus‐host disease (GVHD) prevention

    Recent advances in graft‐versus‐host disease (GVHD) prevention de réir Bruce R. Blazar, Robert Korngold, Andrea R. Daniel

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells

    Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells de réir Jakub Tolar, Keli L. Hippen, Bruce R. Blazar

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Emerging strategies to boost thymic function

    Emerging strategies to boost thymic function de réir Georg A. Holländer, Werner Krenger, Bruce R. Blazar

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy

    Advances in targeting co‐inhibitory and co‐stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy de réir Leslie S. Kean, Laurence A. Turka, Bruce R. Blazar

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    Busulfan disposition in children

    Busulfan disposition in children de réir LB Grochow, William Krivit, CB Whitley, Bruce R. Blazar

    Foilsithe / Cruthaithe 1990
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    B Cells in Chronic Graft-versus-Host Disease

    B Cells in Chronic Graft-versus-Host Disease de réir Stefanie Sarantopoulos, Bruce R. Blazar, Corey Cutler, Jerome Ritz

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    Engineering lymphocyte subsets: tools, trials and tribulations

    Engineering lymphocyte subsets: tools, trials and tribulations de réir Carl H. June, Bruce R. Blazar, James L. Riley

    Foilsithe / Cruthaithe 2009
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    PKC-θ function at the immunological synapse: prospects for therapeutic targeting

    PKC-θ function at the immunological synapse: prospects for therapeutic targeting de réir Alexandra Zanin‐Zhorov, Michael L. Dustin, Bruce R. Blazar

    Foilsithe / Cruthaithe 2011
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    CD4+ AND CD8+ T CELLS EACH CAN UTILIZE A PERFORIN-DEPENDENT PATHWAY TO MEDIATE LETHAL GRAFT-VERSUS-HOST DISEASE IN MAJOR HISTOCOMPATIBILITY COMPLEX-DISPARATE RECIPIENTS1

    CD4+ AND CD8+ T CELLS EACH CAN UTILIZE A PERFORIN-DEPENDENT PATHWAY TO MEDIATE LETHAL GRAFT-VERSUS-HOST DISEASE IN MAJOR HISTOCOMPATIBILITY COMPLEX-DISPARATE RECIPIENTS1 de réir Bruce R. Blazar, Patricia A. Taylor, Daniel A. Vallera

    Foilsithe / Cruthaithe 1997
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality

    The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality de réir Patricia A. Taylor, Christopher J. Lees, Bruce R. Blazar

    Foilsithe / Cruthaithe 2002
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: